Cadrenal Therapeutics, Inc. — DEFA14A Filings
4 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Cadrenal Therapeutics, Inc. (CVKD), sorted by most recent first. Each row links to the full filing on EdgarLookup. Cadrenal Therapeutics, Inc. has filed 4 DEFA14A documents with the SEC since 2022. To view all SEC filings by Cadrenal Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-25-069615 | Jul 31, 2025 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-24-052088 | Jun 12, 2024 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-23-072829 | Aug 31, 2023 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-23-072826 | Aug 31, 2023 | — |